Endoscopic Ultrasound-Celiac plexus neurolysis for Cancer pain in alcohol intolerance patient; Retrospective analysis of the utility of endoscopic ulatrasound-guided celiac plexus neurolysis using phenol.

Endoscopic Ultrasound-Celiac plexus neurolysis for Cancer pain in alcohol intolerance patient; Retrospective analysis of the utility of endoscopic ulatrasound-guided celiac plexus neurolysis using phenol. - A feasibility study of EUS-CPN using phenol.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000008129

Enrollment

Registered

2012-06-18

Start date

2012-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who underwent EUS-CPN for cancer pain.

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who underwent EUS-CPN.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Pain relief effect at 7 days after the treatment (ratio of effective cases)	—

Secondary

Measure	Time frame
Ratio of complete pain relief cases at 7 days after the treatment, Difference of VAS between before and 7 days after the treatment, duration of pain relief effect and incidence of complications.	—

Countries

Japan

Contacts

Public ContactHirotoshi Ishiwatari

Sapporo Medical University 4th department of Internal Medicine

ishihiro@sapmed.ac.jp011-611-2111

Outcome results